OMCL insider trading

NasdaqGS Healthcare

OMNICELL, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
957
Last 90 days
17
Buys / sells
0% / 34%
Market cap
$1.82B

About OMNICELL, INC.

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Company website: www.omnicell.com

OMCL insider activity at a glance

FilingIQ has scored 957 insider transactions for OMCL since May 20, 2014. The most recent filing in our index is dated Apr 1, 2026.

Across the full history, 3 open-market purchases and 323 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on OMCL insider trades is 59.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

13F funds holding OMCL

Frequently asked

How many insider trades does FilingIQ track for OMCL?
FilingIQ tracks 957 Form 4 insider transactions for OMCL (OMNICELL, INC.), covering filings from May 20, 2014 onwards. 17 of those were filed in the last 90 days.
Are OMCL insiders net buyers or net sellers?
Across the full Form 4 history for OMCL, 3 transactions (0%) were open-market purchases and 323 (34%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does OMCL insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is OMCL in?
OMNICELL, INC. (OMCL) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $1.82B.

Methodology & sources

Every OMCL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.